StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.20−0.03 (-13.13%)

Close on Nov 16, 2026Market cap $2.73MP/E –Yield –

VolitionRx ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

VolitionRx's ebitda for the twelve months ending Jun 30, 2026 was -$18.55M. For fiscal 2025 it was -$20.75M. The highest annual figure on record is -$2.49M in fiscal 2011.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$20.75M–
FY2024Dec 31, 2024-$25.91M–
FY2023Dec 31, 2023-$34.84M–
FY2022Dec 31, 2022-$30.84M–
FY2021Dec 31, 2021-$27.39M–
FY2020Dec 31, 2020-$20.53M–
FY2019Dec 31, 2019-$15.37M–
FY2018Dec 31, 2018-$17.26M–
FY2017Dec 31, 2017-$14.17M–
FY2016Dec 31, 2016-$12.12M–
FY2015Dec 31, 2015-$9.77M–
FY2014Dec 31, 2014-$5.81M–
FY2013Dec 31, 2013-$4.43M–
FY2012Dec 31, 2012-$3.95M–
FY2011Dec 31, 2011-$2.49M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.97M–
Q1 FY2026Mar 31, 2026-$5.14M–
Q4 FY2025Dec 31, 2025-$4.59M–
Q3 FY2025Sep 30, 2025-$4.85M–
Q2 FY2025Jun 30, 2025-$6.05M–
Q1 FY2025Mar 31, 2025-$5.27M–
Q4 FY2024Dec 31, 2024-$5.49M–
Q3 FY2024Sep 30, 2024-$5.58M–
Q2 FY2024Jun 30, 2024-$6.72M–
Q1 FY2024Mar 31, 2024-$8.12M–
Q4 FY2023Dec 31, 2023-$8.44M–
Q3 FY2023Sep 30, 2023-$8.36M–
Q2 FY2023Jun 30, 2023-$9.26M–
Q1 FY2023Mar 31, 2023-$8.77M–
Q4 FY2022Dec 31, 2022-$7.76M–
Q3 FY2022Sep 30, 2022-$7.76M–
Q2 FY2022Jun 30, 2022-$7.87M–
Q1 FY2022Mar 31, 2022-$7.45M–
Q4 FY2021Dec 31, 2021-$8.55M–
Q3 FY2021Sep 30, 2021-$7.33M–
Q2 FY2021Jun 30, 2021-$5.66M–
Q1 FY2021Mar 31, 2021-$5.86M–
Q4 FY2020Dec 31, 2020-$5.47M–
Q3 FY2020Sep 30, 2020-$4.34M–
Q2 FY2020Jun 30, 2020-$5.03M–
Q1 FY2020Mar 31, 2020-$5.69M–
Q4 FY2019Dec 31, 2019-$3.56M–
Q3 FY2019Sep 30, 2019-$4.01M–
Q2 FY2019Jun 30, 2019-$3.98M–
Q1 FY2019Mar 31, 2019-$3.82M–
Q4 FY2018Dec 31, 2018-$4.09M–
Q3 FY2018Sep 30, 2018-$4.29M–
Q2 FY2018Jun 30, 2018-$4.40M–
Q1 FY2018Mar 31, 2018-$4.47M–
Q4 FY2017Dec 31, 2017-$3.88M–
Q3 FY2017Sep 30, 2017-$3.73M–
Q2 FY2017Jun 30, 2017-$3.31M–
Q1 FY2017Mar 31, 2017-$3.25M–
Q4 FY2016Dec 31, 2016-$3.40M–
Q3 FY2016Sep 30, 2016-$3.40M–

More VolitionRx figures

See a number that looks wrong?